Skip to content
★ Sign in to follow
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€46k
▼ Sales (0 ops.)
—

Latest filing published 14 Jun 2023 for Bionano Genomics, Inc., €46k.

Filing timeline

BuySale
Hannah Mamuszka

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 14 Jun 2023 · 1243 days ago · €46k
    -88.8%
    Entry US$444.00 · Close at T+365 US$49.80

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Hannah Mamuszka: trading record in brief

Only one filing by Hannah Mamuszka is known so far (14 June 2023): an open-market purchase, €46k, in Bionano Genomics, Inc. That is too little to draw conclusions. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Hannah Mamuszka

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    DirectorExecutivesBionano Genomics, Inc.
    50,000 USD31SEC
    65,789 shares@ US$0.76100.0% of flowCommon StockSEC:0001411690-23-000034:0
    Canonical exit: 11 Sept 2023 (T+90)

1 of 1 declaration